CLINICAL TRIALS PROFILE FOR ONZETRA XSAIL
✉ Email this page to a colleague
All Clinical Trials for ONZETRA XSAIL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03338920 ↗ | Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents | Recruiting | Avanir Pharmaceuticals | Phase 3 | 2017-11-02 | This study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent participants, 12 through 17 years of age. |
NCT03338920 ↗ | Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents | Recruiting | Currax Pharmaceuticals | Phase 3 | 2017-11-02 | This study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent participants, 12 through 17 years of age. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ONZETRA XSAIL
Condition Name
Clinical Trial Locations for ONZETRA XSAIL
Trials by Country
Clinical Trial Progress for ONZETRA XSAIL
Clinical Trial Phase
Clinical Trial Sponsors for ONZETRA XSAIL
Sponsor Name